With three Covid-19 vaccines proving effective, we ask fund manager John Bowler and Data Insights Unit head Mark Ainsworth what comes next as regards the pandemic, and what the future holds for healthcare investing.
To read this article, you need a subscription to Investment Officer. If you don't have a subscription yet, click on 'Subscribe' to see the various subscription options.
